amiodarone has been researched along with Sepsis in 9 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone was stopped, and the patient was treated with steroids, which improved his symptoms and organ dysfunctions." | 5.56 | Amiodarone Toxicity Presenting with Acute Onset of Systemic Inflammatory Response Syndrome and Multiorgan Failure Mimicking Sepsis. ( Ijaz, M; Jasti, Y; Khan, A; Kugasia, IR, 2020) |
| " We identified factors associated with IV AF treatments (?-blockers [BBs], calcium channel blockers [CCBs], digoxin, or amiodarone) during sepsis." | 3.83 | Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study. ( Benjamin, EJ; Evans, SR; Walkey, AJ; Winter, MR, 2016) |
| "Amiodarone was stopped, and the patient was treated with steroids, which improved his symptoms and organ dysfunctions." | 1.56 | Amiodarone Toxicity Presenting with Acute Onset of Systemic Inflammatory Response Syndrome and Multiorgan Failure Mimicking Sepsis. ( Ijaz, M; Jasti, Y; Khan, A; Kugasia, IR, 2020) |
| "Amiodarone is a class III antiarrhythmic agent, a multichannel blocker (Ca++, Na+, and K+), and a noncompetitive α- and β-adrenergic blocker in cardiac cells." | 1.39 | The protective effect of amiodarone in lung tissue of cecal ligation and puncture-induced septic rats: a perspective from inflammatory cytokine release and oxidative stress. ( Bayir, Y; Bilgin, BC; Cadirci, E; Halici, Z; Polat, B; Unal, D; Vancelik, S; Yuksel, TN, 2013) |
| "Flecainide is an antiarrhythmic drug that blocks sodium channels during phase 0 of cardiac action potential, delaying conduction and reducing contractility." | 1.36 | [Flecainide poisoning]. ( Bobillo, B; Diz Gómez, JC; Doniz Campos, M; Filgueira, P; Illodo Miramontes, G; Otero Amoedo, T; Rey López, F, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Gillmann, HJ | 1 |
| Busche, P | 1 |
| Leffler, A | 1 |
| Stueber, T | 1 |
| Ittzes, B | 1 |
| Szentkiralyi, E | 1 |
| Szabo, Z | 1 |
| Batai, IZ | 1 |
| Gyorffy, O | 1 |
| Kovacs, T | 1 |
| Batai, I | 1 |
| Kerenyi, M | 1 |
| Kugasia, IR | 1 |
| Ijaz, M | 1 |
| Khan, A | 1 |
| Jasti, Y | 1 |
| Bosch, NA | 1 |
| Rucci, JM | 1 |
| Massaro, JM | 1 |
| Winter, MR | 2 |
| Quinn, EK | 1 |
| Chon, KH | 1 |
| McManus, DD | 1 |
| Walkey, AJ | 2 |
| Heijman, J | 1 |
| Dobrev, D | 1 |
| Polat, B | 1 |
| Cadirci, E | 1 |
| Halici, Z | 1 |
| Bayir, Y | 1 |
| Unal, D | 1 |
| Bilgin, BC | 1 |
| Yuksel, TN | 1 |
| Vancelik, S | 1 |
| Evans, SR | 1 |
| Benjamin, EJ | 1 |
| Doniz Campos, M | 1 |
| Illodo Miramontes, G | 1 |
| Bobillo, B | 1 |
| Otero Amoedo, T | 1 |
| Filgueira, P | 1 |
| Rey López, F | 1 |
| Diz Gómez, JC | 1 |
| Schuetz, P | 1 |
| Eriksson, U | 1 |
| Christ-Crain, M | 1 |
| Zulewski, H | 1 |
| Miller, B | 1 |
9 other studies available for amiodarone and Sepsis
| Article | Year |
|---|---|
Effectiveness of amiodarone versus digitalis for heart rate control in critically ill patients with new-onset atrial fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Critical Illness; | 2022 |
Amiodarone that has antibacterial effect against human pathogens may represent a novel catheter lock.
Topics: Acinetobacter baumannii; Amiodarone; Anti-Bacterial Agents; Catheter-Related Infections; Escherichia | 2020 |
Amiodarone Toxicity Presenting with Acute Onset of Systemic Inflammatory Response Syndrome and Multiorgan Failure Mimicking Sepsis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Multiple Organ Failure; Sepsis; Systemic Inf | 2020 |
Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium | 2021 |
Pleiotropic actions of amiodarone: still puzzling after half a century.
Topics: Amiodarone; Animals; Lung; Male; Protective Agents; Sepsis | 2013 |
The protective effect of amiodarone in lung tissue of cecal ligation and puncture-induced septic rats: a perspective from inflammatory cytokine release and oxidative stress.
Topics: Amiodarone; Animals; Cecum; Cytokines; Dinoprost; Glutathione; Ligation; Lung; Male; Oxidative Stres | 2013 |
Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fib | 2016 |
[Flecainide poisoning].
Topics: Aged; Amiodarone; Atrial Fibrillation; Cholecystectomy; Cholecystitis; Electrocardiography; Emergenc | 2010 |
[Amiodarone-induced thyrotoxicosis: a diagnostic and therapeutic challenge].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Atrial Fibrillation; Atrial Flutter; Carbima | 2005 |